THE COTTLE GROUP

The Cottle Group develops cell-based gene therapy technologies and point-of-care devices to improve the lives of patients with inherited metabolic diseases. Our research employs cutting edge techniques from life sciences and bioengineering principles to solve challenging biomedical problems. We are devoted to preparing the next generation of the most capable and ethically responsible bioengineers by providing opportunities for quality research training, professional development, and outreach service activities.
Our mission is to train the next generation of researchers to develop innovative technologies and methods for therapies and point-of-care tools that improve the lives of patients with inherited metabolic diseases.
Our lab is in Rhodes Engineering Research Center at Clemson University in Clemson, SC.